Variant report
Variant | esv3376410 |
---|---|
Chromosome Location | chr7:55776708-55778806 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541498106 | chr7:55776762-55776763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559891436 | chr7:55776818-55776819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143254751 | chr7:55776819-55776820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537313545 | chr7:55776822-55776823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536947654 | chr7:55776837-55776838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192414674 | chr7:55776865-55776866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563570104 | chr7:55776970-55776971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531602964 | chr7:55776973-55776974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549819756 | chr7:55776979-55776980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs151247868 | chr7:55777000-55777001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529079633 | chr7:55777005-55777006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547234995 | chr7:55777018-55777019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183186993 | chr7:55777025-55777026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76439744 | chr7:55777037-55777038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs202117907 | chr7:55777041-55777042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6961483 | chr7:55777042-55777043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
17 | rs569572768 | chr7:55777043-55777044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376084937 | chr7:55777044-55777045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553137790 | chr7:55777061-55777062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537716910 | chr7:55777089-55777090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555796523 | chr7:55777132-55777133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185142228 | chr7:55777237-55777238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535229461 | chr7:55777278-55777279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553645879 | chr7:55777291-55777292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377583963 | chr7:55777325-55777326 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143964471 | chr7:55777329-55777330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375201729 | chr7:55777339-55777340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368215261 | chr7:55777355-55777356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144759228 | chr7:55777484-55777485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10546560 | chr7:55777485-55777486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557285039 | chr7:55777489-55777490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565675874 | chr7:55777490-55777491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543936137 | chr7:55777497-55777498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200425939 | chr7:55777502-55777503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150239620 | chr7:55777504-55777505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75945323 | chr7:55777510-55777511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575555788 | chr7:55777519-55777520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62456561 | chr7:55777522-55777523 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs371874857 | chr7:55777523-55777524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374011664 | chr7:55777547-55777548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71978405 | chr7:55777582-55777583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7458867 | chr7:55777584-55777585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201095687 | chr7:55777598-55777599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201433352 | chr7:55777599-55777600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550967847 | chr7:55777625-55777626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182553006 | chr7:55777626-55777627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs199636113 | chr7:55777642-55777643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149428632 | chr7:55777650-55777651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143907215 | chr7:55777652-55777653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
50 | rs188426618 | chr7:55777654-55777655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal cancer | 21851588 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung cancer | 21911935 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung cancer | 17925434 | CNVD |
Glioma | 24330732 | CNVD |
Lung adenocarcinoma | 23938291 | CNVD |
Glioma | 17634744 | CNVD |
Oral squamous cell carcinoma | 19276369 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Lung cancer | 20031968 | CNVD |
Glioblastoma | 17090523 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Glioma | 17123091 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Breast cancer | 17142309 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:55767600-55777800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr7:55767800-55778000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr7:55767800-55778000 | Weak transcription | HMEC | breast |
4 | chr7:55775000-55777800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr7:55775800-55776800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr7:55776200-55777800 | Weak transcription | NHEK | skin |
7 | chr7:55777000-55779200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
8 | chr7:55777800-55778400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr7:55777800-55778800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr7:55777800-55779000 | Enhancers | NHEK | skin |
11 | chr7:55778000-55778200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr7:55778000-55778600 | Enhancers | HMEC | breast |